Published in Shock on July 01, 2008
EMT and tumor metastasis. Clin Transl Med (2015) 1.29
The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol (2010) 1.23
Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation. Am J Physiol Heart Circ Physiol (2010) 1.11
Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J Biol Chem (2009) 1.11
IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol (2009) 1.08
Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin Exp Immunol (2014) 1.04
Neutrophil chemokines and their role in IL-18-mediated increase in neutrophil O2- production and intestinal edema following alcohol intoxication and burn injury. Am J Physiol Gastrointest Liver Physiol (2009) 0.96
ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury. Oxid Med Cell Longev (2016) 0.84
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. Physiol Genomics (2011) 0.84
Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation. Oncotarget (2016) 0.82
High-sodium intake aggravates myocardial injuries induced by aldosterone via oxidative stress in Sprague-Dawley rats. Acta Pharmacol Sin (2012) 0.79
Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis. Burns Trauma (2013) 0.78
Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One (2013) 0.75
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol (2008) 2.18
Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2006) 1.69
Stem cells as a potential future treatment of pediatric intestinal disorders. J Pediatr Surg (2008) 1.57
Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol (2006) 1.55
Cytokines in necrotizing enterocolitis. Shock (2006) 1.53
Sex differences in the myocardial inflammatory response to acute injury. Shock (2005) 1.52
Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection. Ann Thorac Surg (2009) 1.51
Experimental therapies for hypoxia-induced pulmonary hypertension during acute lung injury. Shock (2006) 1.50
Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol (2006) 1.48
Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab (2004) 1.44
VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol (2008) 1.44
Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protection. Ann Thorac Surg (2011) 1.42
High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock (2006) 1.40
Sex steroids and stem cell function. Mol Med (2008) 1.34
17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol (2006) 1.29
Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock (2006) 1.28
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock (2010) 1.28
Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol (2009) 1.23
In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery (2007) 1.22
Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab (2007) 1.19
Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation (2006) 1.18
Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res (2005) 1.17
Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine (2008) 1.16
STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol (2007) 1.14
The role of estrogen in cardiovascular disease. J Surg Res (2003) 1.13
Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy. J Urol (2008) 1.13
Mechanisms of sex differences in TNFR2-mediated cardioprotection. Circulation (2008) 1.13
IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proc Natl Acad Sci U S A (2009) 1.12
Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol (2007) 1.11
Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery (2009) 1.11
TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2002) 1.11
Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2004) 1.10
IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int (2009) 1.10
Animal models of myocardial and vascular injury. J Surg Res (2009) 1.09
Sex dimorphisms in activated mesenchymal stem cell function. Shock (2006) 1.05
beta-Blockers in sepsis: reexamining the evidence. Shock (2009) 1.05
Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circ Physiol (2008) 1.05
Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery (2010) 1.05
Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2008) 1.04
Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am J Physiol Lung Cell Mol Physiol (2004) 1.04
Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. Am J Physiol Heart Circ Physiol (2006) 1.04
Brief exposure to exogenous testosterone increases death signaling and adversely affects myocardial function after ischemia. Am J Physiol Regul Integr Comp Physiol (2006) 1.04
Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol (2010) 1.03
Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res (2010) 1.02
Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab (2007) 1.02
Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery (2008) 1.01
Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock (2007) 1.01
Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg (2009) 1.00
Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res (2004) 1.00
The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med (2008) 0.98
Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol (2007) 0.98
Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res (2007) 0.98
Vascular endothelial growth factor improves myocardial functional recovery following ischemia/reperfusion injury. J Surg Res (2008) 0.97
P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock (2004) 0.97
Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock (2008) 0.97
TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res (2006) 0.97
Stem cell therapy in myocardial repair and remodeling. J Am Coll Surg (2008) 0.96
Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock (2006) 0.96
p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann Thorac Surg (2005) 0.96
Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery (2010) 0.95
Surgically relevant aspects of stem cell paracrine effects. Surgery (2008) 0.95
TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol (2008) 0.95
The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock (2007) 0.95
Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg (2011) 0.95
Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2010) 0.94
TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One (2010) 0.94
Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg (2006) 0.94
Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg (2009) 0.94
Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol (2010) 0.93
The struggle for iron: gastrointestinal microbes modulate the host immune response during infection. J Leukoc Biol (2007) 0.93
Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. J Surg Res (2008) 0.93
Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression. Ann Thorac Surg (2006) 0.92
Gender dimorphisms in progenitor and stem cell function in cardiovascular disease. J Cardiovasc Transl Res (2010) 0.92
Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery. Surgery (2009) 0.92
MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. Am J Physiol Cell Physiol (2009) 0.92